In this video, Dr. Vikramaditya Yadav of the University of British Columbia talks about using a unique biosynthesis platform to productively produce bioidentical, high purity, high grade cannabinoids. InMed collaborates with Dr. Yadav’s laboratory in developing a proprietary biosynthesis platform.
InMed presents Phase 2 clinical study results at 12th World Congress on Itch
At the 12th World Congress on Itch (WCI), held in Miami on November 5-7, 2023, InMed’s Senior VP, Clinical and Regulatory Affairs, Alexandra Mancini presented